Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Although not the most prevalent comorbid condition in patients with T2DM, heart failure was the most fatal in a 17-year long nationwide real-life cohort study.
Read More »Heart Failure in T2DM: Ready for Prime Time?
COVID-19 Severity Perceived in Recently Diagnosed Diabetes Patients
Newly-diagnosed diabetes and admission hyperglycemia are linked to rapid respiratory deterioration in COVID-19 patients.
Read More »PRE-D Trial: Effect of Metformin, Dapagliflozin, or Exercise on Prediabetes Outcomes
Multiple treatments were compared to improve outcomes in patients with prediabetes.
Read More »Impact of Physical Activity and Metformin on Postprandial Glucose
Lifestyle modifications as first-line treatment have paramount importance on the quality of life.
Read More »Skim Milk vs. Whole Milk: What’s the Healthier Option?
Does the fat content of dairy products play a role in the development of metabolic syndrome (MetS)?
Read More »Role of Magnesium in Type 2 Diabetes and Stroke
Adequate amounts of magnesium in the diet could reduce the risk of type 2 and cerebral vascular incidents.
Read More »Prolonged Use of Proton Pump Inhibitors Linked to Increased Risk of T2DM
Long-term users of the acid reflux drugs known as Proton Pump Inhibitors (PPIs) have a 24% higher risk of developing type 2 diabetes than non-PPI users.
Read More »Old vs. New: Which T2D Agents Have the Best Renal Outcomes?
How do DPP-4 inhibitors and sulfonylureas compare to SGLT2is and GLP-1 agonists regarding renal outcomes?
Read More »Another Oral Combination Antidiabetic Agent
Dual and triple therapy just got a little easier.
Read More »Real-World Evidence in Support of Continuous Glucose Monitoring
Insulin delivery method or blood glucose monitoring – which is more important?
Read More »